CAS: 1442472-39-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ripretinib REF: AN-AG01EO7KCAS: 1442472-39-0 | 98% | To inquire | Thu 09 May 24 |
 | Ripretinib REF: TM-T8482CAS: 1442472-39-0 | 99.72% | 74.00 €~1,846.00 € | Thu 16 May 24 |
 | Ripretinib REF: TR-R295060CAS: 1442472-39-0 | - - - | 15,186.00 € | Thu 20 Jun 24 |
 | Ripretinib (DCC-2618) REF: 3D-SHC47239CAS: 1442472-39-0 | Min. 95% | 189.00 €~711.00 € | Thu 20 Jun 24 |
Ripretinib
CAS:1442472-39-0
Formula:
C24H21BrFN5O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
510.3582
Ref: AN-AG01EO7K
| 10mg | 193.00 € | |
| 25mg | 275.00 € | |
| 50mg | 612.00 € | |
| 100mg | To inquire | |
| 250mg | To inquire |
Estimated delivery in United States, on Thursday 9 May 2024
Ripretinib
CAS:1442472-39-0
Ripretinib (DCC-2618) is an orally bioavailable inhibitor of KIT and PDGFRA.
Formula:
C24H21BrFN5O2
Purity:
99.72%
Color and Shape:
Solid
Molecular weight:
510.36
- Inhibitors
- Angiogenesis
- Apoptosis
- Tyrosine Kinase/Adaptors
- See more categories
- VEGFR
- PDGFR
- FLT
- c-Kit
Ref: TM-T8482
| 1mg | 74.00 € | |
| 2mg | 95.00 € | |
| 5mg | 162.00 € | |
| 10mg | 270.00 € | |
| 25mg | 459.00 € | |
| 50mg | 666.00 € | |
| 100mg | 917.00 € | |
| 500mg | 1,846.00 € | |
| 1ml*10 (DMSO) | 198.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
Ref: TR-R295060
| 75mg | 15,186.00 € |
Estimated delivery in United States, on Thursday 20 Jun 2024
Ripretinib (DCC-2618)
CAS:1442472-39-0
Ripretinib is a potent, orally bioavailable inhibitor of the tyrosine kinase activity of RET. It …
Formula:
C24H21BrFN5O2
Purity:
Min. 95%
Molecular weight:
510.36 g/mol
Ref: 3D-SHC47239
| 1mg | 189.00 € | |
| 2mg | 272.00 € | |
| 5mg | 399.00 € | |
| 10mg | 498.00 € | |
| 25mg | 711.00 € |
Estimated delivery in United States, on Thursday 20 Jun 2024
